Choosing the Right GLP-1: A Patient’s Guide in 2025
Meet Sarah, a 38-year-old working professional with a BMI of 33. She’s tried diets, apps, and group classes — but nothing delivers sustainable weight loss. In 2025, she considers GLP-1 therapy. Here’s how she found the right option.
🔍 Step 1: Identify the Goal
Sarah wanted to lose 15–20% of her body weight within a year, without surgical intervention. Her physician recommended GLP-1 agonists.
📋 Step 2: Compare Available Options
- Semaglutide (Ozempic): Once-weekly injection, strong weight loss data, affordable
- Tirzepatide (Mounjaro): Faster results, dual-action, higher cost
- Liraglutide (Saxenda): Daily dose, ideal for gradual progress
💉 Step 3: Evaluate Lifestyle Fit
Sarah chose Mounjaro for its dual mechanism and rapid outcomes. She tolerated the weekly injection well and noticed reduced cravings in the first month.
✅ Final Outcome
After 6 months on Tirzepatide with diet adjustments, Sarah lost 18% of her body weight. Her energy improved, and she avoided weight rebound — a success story backed by science.
🧭 Explore more case-based comparisons in our GLP-1 Drug Guide.
